ESC Premium Access

Advances in structural heart interventions

Event: ESC Congress 2018
Topic: Noncoronary Cardiac Intervention
Session type: Abstract Sessions
Date: 27 August 2018
Time: 08:30 - 10:00


6 presentations in this session

Safety and feasibility of an early ambulation protocol after transfemoral transcatheter aortic valve implantation: results of the early mobilisation after TF-TAVI (MobiTAVI) trial

Speaker: Mr J. Vendrik (Amsterdam, NL)

The impact of residual mitral valve regurgitation on outcome after MitraClip therapy

Speaker: Doctor D. Reichart (Munich, DE)

Assessment of long-term structural deterioration of transcatheter aortic bioprosthetic valves using standardized new european definitions, a multicenter study

Speaker: Doctor A. Sokoloff (Rouen, FR)

6 month follow up results from the european transcatheter tricuspid valve repair multicenter trial

Speaker: Assistant Professor R. Von Bardeleben (Mainz, DE)

Up to two-year outcomes from the multicenter CE trial of transcatheter mitral valve repair in patients with functional mitral regurgitation

Speaker: Doctor A. Latib (New York, US)

Panel discussion.


5 speakers from this session

Mr Jeroen Vendrik

Academic Medical Center of Amsterdam, Amsterdam (Netherlands (The))
0 follower

Doctor Daniel Reichart

Ludwig-Maximilians University, Munich (Germany)
0 follower

Doctor Anastasia Sokoloff

University Hospital of Rouen, Rouen (France)
0 follower

Assistant Professor Ralph Stephan Von Bardeleben

University Medical Center of Mainz, Mainz (Germany)
51 presentations
1 follower

Doctor Azeem Latib

Montefiore Medical Center (Bronx), New York (United States of America)
9 presentations
0 follower

This platform is supported by

logo Novo Nordisk